Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Sil overexpression in lung cancer characterizes tumors with increased mitotic activity

Abstract

Sil (SCL interrupting locus) was cloned from the most common chromosomal rearrangement in T-cell acute lymphoblastic leukemia. It is an immediate early gene whose expression is associated with cell proliferation. Sil protein levels are tightly regulated during the cell cycle, reaching peak levels in mitosis and disappearing on transition to G1. A recent study found Sil to be one of 17 genes whose overexpression in primary adenocarcinomas predicts metastatic spread. We hypothesized that Sil might have a role in carcinogenesis. To address this question, we utilized several approaches. Using a multitumor tissue array, we found that Sil protein expression was increased mostly in lung cancer, but also at lower levels, in a subset of other tumors. Microarray gene expression analysis and immunohistochemistry of lung cancer samples verified these observations. Sil gene expression in lung cancer correlated with the expression of several kinetochore check-point genes and with the histopathologic mitotic index. These observations suggest that overexpression of the Sil gene characterizes tumors with increased mitotic activity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Aplan PD, Lombardi DP, Ginsberg AM, Cossman J, Bertness VL and Kirsch IR . (1990). Science, 250, 1426–1429.

  • Aplan PD, Lombardi DP and Kirsch IR . (1991). Mol. Cell. Biol., 11, 5462–5469.

  • Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ and Meyerson M . (2001). Proc. Natl. Acad. Sci. USA, 98, 13790–13795.

  • Collazo-Garcia N, Scherer P and Aplan PD . (1995). Genomics, 30, 506–513.

  • Golling G, Amsterdam A, Sun Z, Antonelli M, Maldonado E, Chen W, Burgess S, Haldi M, Artzt K, Farrington S, Lin SY, Nissen RM and Hopkins N . (2002). Nat. Genet., 31, 135–140.

  • Izraeli S, Colaizzo-Anas T, Bertness VL, Mani K, Aplan PD and Kirsch IR . (1997). Cell Growth Differ., 8, 1171–1179.

  • Izraeli S, Lowe LA, Bertness VL, Campaner S, Hahn H, Kirsch IR and Kuehn MR . (2001). Genesis, 31, 72–77.

  • Izraeli S, Lowe LA, Bertness VL, Good DJ, Dorward DW, Kirsch IR and Kuehn MR . (1999). Nature, 399, 691–694.

  • Kaminski N and Friedman N . (2002). Am. J. Respir. Cell Mol. Biol., 27, 125–132.

  • Liu ST, Chan GK, Hittle JC, Fujii G, Lees E and Yen TJ . (2003). Mol. Biol. Cell., 14, 1638–1651.

  • Lynch J, Pattekar R, Barnes DM, Hanby AM, Camplejohn RS, Ryder K and Gillett CE . (2002). J. Pathol., 196, 275–279.

  • Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV and Benezra R . (2001). Nature, 409, 355–359.

  • Musacchio A and Hardwick KG . (2002). Nat. Rev. Mol. Cell. Biol., 3, 731–741.

  • Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N and Phinney DG . (2003). Proc. Natl. Acad. Sci. USA, 100, 8407–8411.

  • Ramaswamy S, Ross KN, Lander ES and Golub TR . (2003). Nat. Genet., 33, 49–54.

  • Rattner JB, Hendzel MJ, Furbee CS, Muller MT and Bazett-Jones DP . (1996). J. Cell. Biol., 134, 1097–1107.

  • Starr DA, Saffery R, Li Z, Simpson AE, Choo KH, Yen TJ and Goldberg ML . (2000). J Cell Sci, 113, 1939–1950.

  • Takahashi T, Haruki N, Nomoto S, Masuda A, Saji S, Osada H and Takahashi T . (1999). Oncogene, 18, 4295–4300.

  • Travis WD, Colby TV, Corrin B, Shimosato Y and Brambilla E . (1999). Histological Typing of Lung and Pleural Tumours, 3rd edn Springer: Berlin.

    Book  Google Scholar 

  • Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA and Baylin SB . (2003). Nature, 422, 313–317.

  • Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, Matese JC, Perou CM, Hurt MM, Brown PO and Botstein D . (2002). Mol. Biol. Cell, 13, 1977–2000.

  • Zhou J, Yao J and Joshi HC . (2002). J. Cell Sci., 115, 3547–3555.

Download references

Acknowledgements

We thank Sergey Nemez for the statistical analysis. This study was supported by research grants from the Israel Science Foundation, the Israel Cancer Research foundation and from Tel-Aviv University Recanati foundation to S Izraeli. N Kaminski is the Dorothy P and Richard P Simmons chair of Interstitial Lung Diseases at the University of Pittsburgh Medical School. G Rechavi holds the Gregorio and Dora Shapiro Chair for Hematology Malignancies, Sackler School of Medicine, Tel-Aviv University. This work was preformed in partial fulfillment of the requirements for the PhD degree of Ayelet Erez, Sackler Faculty of Medicine, Tel-Aviv University.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Naftali Kaminski or Shai Izraeli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erez, A., Perelman, M., Hewitt, S. et al. Sil overexpression in lung cancer characterizes tumors with increased mitotic activity. Oncogene 23, 5371–5377 (2004). https://doi.org/10.1038/sj.onc.1207685

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207685

Keywords

This article is cited by

Search

Quick links